Celgene's most recent trend suggests a bullish bias. One trading opportunity on Celgene is a Bull Put Spread using a strike $150.00 short put and a strike $140.00 long put offers a potential 15.74% return on risk over the next 26 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $150.00 by expiration. The full premium credit of $1.36 would be kept by the premium seller. The risk of $8.64 would be incurred if the stock dropped below the $140.00 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Celgene is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Celgene is bullish.
The RSI indicator is at 52.93 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Celgene
Is Regeneron a Better Buy Than Celgene?
Mon, 21 Oct 2013 22:54:42 GMT
Motley Fool – Biotech companies Regeneron and Celgene are treating investors to big returns this year. But, is one a better buy than another?
Celgene And NeoStem: 2 Biopharmaceutical Companies Poised For Growth
Mon, 21 Oct 2013 16:33:02 GMT
Seeking Alpha – It wasn't that many years ago that Celgene ( CELG ) was a $38.00 per share stock with a market cap of $17 billion – that was April 18th 2009. Today it sits at its all-time high at $160.58 per share with …
Will Celgene's (CELG) Earnings Streak End?
Mon, 21 Oct 2013 14:40:02 GMT
Zacks – Celgene will report its third quarter earnings on Oct 24.
IBD 50's 6 Top Stocks Reporting Earnings This Week
Sat, 19 Oct 2013 12:02:00 GMT
Investor's Business Daily – IBD 50's 6 Top Stocks Reporting Earnings This Week
Stocks at 1-year highs: Amgen, Starbucks & more
Fri, 18 Oct 2013 16:48:00 GMT
CNBC – There are over 100 S&P 500 stocks soaring to new 52-week highs. The FMHR traders take their positions.
Also on Market Tamer…
Follow Us on Facebook